|Mr. Paul G. Thomas||Founder and Chairman||613.62k||N/A||61|
|Ms. Mary Beth Duseau||Chief Exec. Officer, Pres, Sec. and Director||481.69k||N/A||52|
|Mr. Lars Boesgaard||Chief Financial Officer, VP and Treasurer||312.23k||N/A||47|
|Dr. Michael Becker||Chief Scientific Officer||N/A||N/A||N/A|
|Mr. Kevin Giroux||VP of Sales and Marketing||N/A||N/A||N/A|
Roka Bioscience, Inc., a molecular diagnostics company, focuses on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens in the United States. It provides Atlas instrument, a fully automated molecular diagnostic testing instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single and integrated platform. The company also offers atlas detection assays that include molecular tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin- producing E.coli, and Listeria monocytogenes, as well as related consumable supplies. It serves food processors, third-party contract testing laboratories, and government regulatory authorities. The company was founded in 2009 and is headquartered in Warren, New Jersey.
Sorrento Tech, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.